1-3 of 3
Alla Gimelfarb, MD
Close
Sort by
Journal Articles

Outcomes and a New Prognostic Model in Posttransplantation Lymphoproliferative Disorders (PTLD): Intent-to-Treat (ITT) Analysis of 81 Patients in the Post-Rituximab Era.

Andrew M. Evens, DO, MS, Kevin A. David, MD, Irene Helenowski, PhD, Sheetal M. Kircher, MD, Lauren Mauro, MD, Alla Gimelfarb, MD, Koen Van Besien, MD, Elise Hattersley, MD, Beverly P Nelson, MD, Jayesh Mehta, MD, Leo I. Gordon, MD, Jamile M. Shammo, MD, FASCP, Scott E. Smith, MD, PhD, Sonali Smith, MD
Journal: Blood
Blood (2008) 112 (11): 1776.
https://doi.org/10.1182/blood.V112.11.1776.1776
Published: 2008
Journal Articles

Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Pateints (pts) with Advanced Chronic Lymphoctic Leukemia (CLL): A Comparative Study.

Antonio Jimenez, MD, Mohamed I. Farhat, MD, Stephanie A. Gregory, MD, Mohamad Kassar, MD, Alla Gimelfarb, MD, Marta Batus, MD, Julie Nangia, MD, Neel Shah, MD, Parameswaran Venugopal, MD, Melissa L. Larson, MD, Kent W. Christopherson, PHD, Henry C. Fung, MD
Journal: Blood
Blood (2007) 110 (11): 5044.
https://doi.org/10.1182/blood.V110.11.5044.5044
Published: 2007
Journal Articles

Hematopoietic Cell Transplantation - Comorbidity Index (HCT-CI) as a Surrgoate Marker for Predition of Transplant Outcome for Pateints (pts) with Multiple Myeloma (MM) Undergoing Autologous Stem Cell Transplantation (ASCT): High HCT-CI Score Predicts for Poor Outcome.

Mohamed I. Farhat, MD, Ronald Myint, MD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD, Mohamad Kassar, MD, Alla Gimelfarb, MD, Marta Batus, MD, Julie Nangia, MD, John Maciejewski, MD, Amanda Law, NP, Henry C. Fung, MD
Journal: Blood
Blood (2007) 110 (11): 5104.
https://doi.org/10.1182/blood.V110.11.5104.5104
Published: 2007